Results for patchescapsulesitt translation from English to Finnish

English

Translate

patchescapsulesitt

Translate

Finnish

Translate
Translate

Instantly translate texts, documents and voice with Lara

Translate now

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

English

Finnish

Info

English

placebotransdermal patchescapsulesitt-locf population at least 4 points improvement on adas-cog with no worsening on adcs-cgic and adcs-adl

Finnish

vähintään 4 pisteen paraneminen adas-cog -pisteissä ja adcs-cgig -pistearvon ja adcs-adl -pistearvon pysyminen vähintään lähtöarvossa p-arvo vs. lumelääke * p 0, 05 vs. lumelääkeprometax -depot -laastarit 9, 5 mg/24 n = 251 17, 40, 037 *prometax -kapselit 12 mg/vrkn = 256 19, 0

Last Update: 2008-03-04
Usage Frequency: 2
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

English

placebotransdermal patchescapsulesitt-locf population adas-cog9.5 nmg/24 h = 251 (n=248)12 mg/day n = 256 (n=253)n = 282(n=281)mean baseline ± sd mean change at week 24 ± sd p-value versus placebo adcs-cgic mean score ± sd p-value versus placebo adcs-adl

Finnish

lähtötilanteen keskiarvo ± keskihajonta keskimääräinen muutos viikon 24 kohdalla ± keskihajonta p-arvo vs. lumelääke adcs-cgic pistekeskiarvo ± keskihajonta p-arvo vs. lumelääke adcs-adllähtötilanteen keskiarvo ± keskihajonta keskimääräinen muutos viikon 24 kohdalla ± keskihajonta p-arvo vs. lumelääke * p0, 05 vs. lumelääkeprometax -depot -laastarit 9, 5 mg/24 h n = 251 (n=248) 27, 0 ± 10, 3-0, 6 ± 6, 40, 005* 1(n=248) 3, 9 ± 1, 20 0, 010* 2(n=247) 50, 1 ± 16, 3-0, 1 ± 9, 10, 013* 1prometax -kapselit 12 mg/vrk n = 256 (n=253) 27, 9 ± 9, 4

Last Update: 2008-03-04
Usage Frequency: 2
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Get a better translation with
8,712,138,502 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK